do we know much detail on just what size financial resources Amphastar has? Hoover's says they have about 1000 employees. Haven't found any info on revenues, etc.
How much enox could they supply realistically? If they can't meet a decent percentage of the market, then they would have a less disruptive effect on the pricing duopoly currently enjoyed by NVS and SNY
Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com